TOI
The Oncology Institute, Inc.
Medical - Care Facilities
Market Cap$5.41B
5Y Perf.+1054.3%
Build Your Comparison
Side-by-side financial analysisTOI
AIOT
TRAK
GEOS
Try popular comparisons:
Stock Comparison
TOI vs AIOT vs TRAK vs GEOS
Revenue, margins, valuation, and 5-year total return — side by side.
AIOT
PowerFleet, Inc.
Communication Equipment
Market Cap$574M
5Y Perf.-7.7%
TRAK
ReposiTrak, Inc.
Software - Application
Market Cap$171M
5Y Perf.-38.5%
GEOS
Geospace Technologies Corporation
Oil & Gas Equipment & Services
Market Cap$94M
5Y Perf.-19.2%
TOI vs AIOT vs TRAK vs GEOS — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot |  TOI |  AIOT |  TRAK |  GEOS |
|---|---|---|---|---|
| Industry | Medical - Care Facilities | Communication Equipment | Software - Application | Oil & Gas Equipment & Services |
| Market Cap | $5.41B | $574M | $171M | $94M |
| Revenue (TTM) | $546M | $436M | $23M | $101M |
| Net Income (TTM) | $-44M | $-32M | $7M | $-29M |
| Gross Margin | 14.8% | 55.2% | 85.0% | 14.3% |
| Operating Margin | -6.0% | 1.7% | 32.2% | -30.3% |
| Forward P/E | — | — | 25.4x | — |
| Total Debt | $104M | $287M | $510K | $974K |
| Cash & Equiv. | $34M | $49M | $29M | $26M |
TOI vs AIOT vs TRAK vs GEOS — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
TOI
AIOT
TRAK
GEOS
| Stock | Jun 24 | Jun 26 | Return |
|---|---|---|---|
| The Oncology Instit… (TOI) | 100 | 1154.3 | +1054.3% |
| PowerFleet, Inc. (AIOT) | 100 | 92.3 | -7.7% |
| ReposiTrak, Inc. (TRAK) | 100 | 61.5 | -38.5% |
| Geospace Technologi… (GEOS) | 100 | 80.8 | -19.2% |
Price return only. Dividends and distributions are not included.
Quick Verdict: TOI vs AIOT vs TRAK vs GEOS
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Bottom line: TRAK leads in 3 of 6 categories, making it the strongest pick for profitability and margin quality and capital preservation and lower volatility. PowerFleet, Inc. is the stronger pick specifically for growth and revenue expansion and dividend income and shareholder returns. TOI also leads in specific categories worth noting. This set spans 3 sectors — these stocks serve different portfolio roles, not just different price points.
🥇TRAK emerged as the overall leader. Track its performance:
TOI
The Oncology Institute, Inc.
The Momentum Pick
TOI is the clearest fit if your priority is momentum.
- +100.4% vs TRAK's -54.5%
Best for: momentum
AIOT
PowerFleet, Inc.
The Growth Play
AIOT is the #2 pick in this set and the best alternative if growth exposure is your priority.
- Rev growth 66.3%, EPS growth 60.6%, 3Y rev CAGR 42.2%
- 66.3% revenue growth vs GEOS's -18.3%
- 17.8% yield, 1-year raise streak, vs TRAK's 0.9%, (2 stocks pay no dividend)
Best for: growth exposure
TRAK
ReposiTrak, Inc.
The Income Pick
TRAK carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- Dividend streak 4 yrs, beta 0.97, yield 0.9%
- 4.7% 10Y total return vs AIOT's -11.5%
- Lower volatility, beta 0.97, Low D/E 1.0%, current ratio 6.09x
- Beta 0.97, yield 0.9%, current ratio 6.09x
Best for: income & stability and long-term compounding
GEOS
Geospace Technologies Corporation
The Secondary Option
GEOS lags the leaders in this set but could rank higher in a more targeted comparison.
Best for: energy exposure
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth |  AIOT | 66.3% revenue growth vs GEOS's -18.3% |
| Quality / Margins |  TRAK | 31.0% margin vs GEOS's -28.9% |
| Stability / Safety | TRAK | Beta 0.97 vs AIOT's 2.71, lower leverage |
| Dividends | AIOT | 17.8% yield, 1-year raise streak, vs TRAK's 0.9%, (2 stocks pay no dividend) |
| Momentum (1Y) |  TOI | +100.4% vs TRAK's -54.5% |
| Efficiency (ROA) | TRAK | 0.1% ROA vs TOI's -26.5%, ROIC 21.4% vs -41.2% |
TOI vs AIOT vs TRAK vs GEOS — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
FY 2025
FY 2024
FY 2025
FY 2025
TOI vs AIOT vs TRAK vs GEOS — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
BEST OVERALLTRAKLAGGINGAIOT
Who Leads Where
TRAK leads in 2 of 6 categories
GEOS leads 1 • TOI leads 1 • AIOT leads 0 • 2 tied
Explore the data ↓AIOTPowerFleet, Inc.
0leads
GEOSGeospace Technologies…
1leads
TOIThe Oncology Institut…
1leads
TRAKReposiTrak, Inc.
2leads
6 Total Categories
CATEGORYLEADERvs TOIvs GEOSMETRICS WON
Income & Cash FlowRevenue, margins, and cash flow strength
TRAK4/6
Valuation MetricsMultiples, price ratios, and targets
GEOS2/4
Profitability & EfficiencyROE, ROIC, leverage, and quality scores
TRAK8/9
Total Returns1Y, 3Y, 5Y total returns with dividends
TOI4/6
Risk & VolatilityBeta, volatility, and downside exposure
Tied
—
Analyst OutlookRatings, price targets, and dividends
Tied
—
Income & Cash Flow (Last 12 Months)
TRAK leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
TOI is the larger business by revenue, generating $546M annually — 23.3x TRAK's $23M. TRAK is the more profitable business, keeping 31.0% of every revenue dollar as net income compared to GEOS's -28.9%. On growth, AIOT holds the edge at +47.4% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | TOIThe Oncology Inst… | AIOTPowerFleet, Inc. | TRAKReposiTrak, Inc. | GEOSGeospace Technolo… |
|---|---|---|---|---|
| RevenueTrailing 12 months | $546M | $436M | $23M | $101M |
| EBITDAEarnings before interest/tax | -$26M | $69M | $8M | -$20M |
| Net IncomeAfter-tax profit | -$44M | -$32M | $7M | -$29M |
| Free Cash FlowCash after capex | -$26M | $3M | $7M | -$32M |
| Gross MarginGross profit ÷ Revenue | +14.8% | +55.2% | +85.0% | +14.3% |
| Operating MarginEBIT ÷ Revenue | -6.0% | +1.7% | +32.2% | -30.3% |
| Net MarginNet income ÷ Revenue | -8.0% | -7.4% | +31.0% | -28.9% |
| FCF MarginFCF ÷ Revenue | -4.7% | +0.6% | +31.9% | -31.3% |
| Rev. Growth (YoY)Latest quarter vs prior year | +41.2% | +47.4% | -0.5% | +9.5% |
| EPS Growth (YoY)Latest quarter vs prior year | +90.5% | -25.5% | +1.8% | -11.7% |
TRAK leads this category, winning 4 of 6 comparable metrics.
Valuation Metrics
GEOS leads this category, winning 2 of 4 comparable metrics.
Valuation Metrics
On an enterprise value basis, TRAK's 19.1x EV/EBITDA is more attractive than AIOT's 51.2x.
| Metric | TOIThe Oncology Inst… | AIOTPowerFleet, Inc. | TRAKReposiTrak, Inc. | GEOSGeospace Technolo… |
|---|---|---|---|---|
| Market CapShares × price | $5.4B | $574M | $171M | $94M |
| Enterprise ValueMkt cap + debt − cash | $5.5B | $813M | $143M | $69M |
| Trailing P/EPrice ÷ TTM EPS | -9.83x | -9.81x | 26.89x | -9.55x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — | 25.43x | — |
| PEG RatioP/E ÷ EPS growth rate | — | — | 0.78x | — |
| EV / EBITDAEnterprise value multiple | — | 51.19x | 19.11x | — |
| Price / SalesMarket cap ÷ Revenue | 10.75x | 1.58x | 7.56x | 0.85x |
| Price / BookPrice ÷ Book value/share | — | 1.13x | 3.64x | 0.74x |
| Price / FCFMarket cap ÷ FCF | — | — | 20.35x | — |
GEOS leads this category, winning 2 of 4 comparable metrics.
Profitability & Efficiency
TRAK leads this category, winning 8 of 9 comparable metrics.
Profitability & Efficiency
TRAK delivers a 0.1% return on equity — every $100 of shareholder capital generates $0 in annual profit, vs $-24 for GEOS. GEOS carries lower financial leverage with a 0.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to AIOT's 0.64x. On the Piotroski fundamental quality scale (0–9), TRAK scores 7/9 vs GEOS's 1/9, reflecting strong financial health.
| Metric | TOIThe Oncology Inst… | AIOTPowerFleet, Inc. | TRAKReposiTrak, Inc. | GEOSGeospace Technolo… |
|---|---|---|---|---|
| ROE (TTM)Return on equity | — | -6.6% | +0.1% | -24.2% |
| ROA (TTM)Return on assets | -26.5% | -3.4% | +0.1% | -19.9% |
| ROICReturn on invested capital | -41.2% | -4.3% | +21.4% | -7.4% |
| ROCEReturn on capital employed | -33.7% | -5.1% | +12.9% | -8.6% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 3 | 7 | 1 |
| Debt / EquityFinancial leverage | — | 0.64x | 0.01x | 0.01x |
| Net DebtTotal debt minus cash | $70M | $238M | -$28M | -$25M |
| Cash & Equiv.Liquid assets | $34M | $49M | $29M | $26M |
| Total DebtShort + long-term debt | $104M | $287M | $509,973 | $974,000 |
| Interest CoverageEBIT ÷ Interest expense | -4.96x | 0.47x | 182.09x | -187.88x |
TRAK leads this category, winning 8 of 9 comparable metrics.
Total Returns (Dividends Reinvested)
TOI leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in TRAK five years ago would be worth $16,299 today (with dividends reinvested), compared to $5,257 for TOI. Over the past 12 months, TOI leads with a +100.4% total return vs TRAK's -54.5%. The 3-year compound annual growth rate (CAGR) favors TOI at 111.1% vs AIOT's -4.0% — a key indicator of consistent wealth creation.
| Metric | TOIThe Oncology Inst… | AIOTPowerFleet, Inc. | TRAKReposiTrak, Inc. | GEOSGeospace Technolo… |
|---|---|---|---|---|
| YTD ReturnYear-to-date | +44.7% | -19.6% | -20.4% | -59.0% |
| 1-Year ReturnPast 12 months | +100.4% | -11.0% | -54.5% | +9.5% |
| 3-Year ReturnCumulative with dividends | +841.3% | -11.5% | +10.7% | -11.0% |
| 5-Year ReturnCumulative with dividends | -47.4% | -11.5% | +63.0% | -17.2% |
| 10-Year ReturnCumulative with dividends | -45.3% | -11.5% | +4.7% | -60.7% |
| CAGR (3Y)Annualised 3-year return | +111.1% | -4.0% | +3.4% | -3.8% |
TOI leads this category, winning 4 of 6 comparable metrics.
Risk & Volatility
Evenly matched — TOI and TRAK each lead in 1 of 2 comparable metrics.
Risk & Volatility
TRAK is the less volatile stock with a 0.97 beta — it tends to amplify market swings less than AIOT's 2.71 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. TOI currently trades 95.2% from its 52-week high vs GEOS's 24.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | TOIThe Oncology Inst… | AIOTPowerFleet, Inc. | TRAKReposiTrak, Inc. | GEOSGeospace Technolo… |
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.95x | 2.71x | 0.97x | 2.09x |
| 52-Week HighHighest price in past year | $5.58 | $5.88 | $21.03 | $29.89 |
| 52-Week LowLowest price in past year | $2.02 | $2.77 | $6.94 | $6.52 |
| % of 52W HighCurrent price vs 52-week peak | +95.2% | +71.8% | +44.7% | +24.3% |
| RSI (14)Momentum oscillator 0–100 | 65.3 | 65.9 | 47.8 | 36.2 |
| Avg Volume (50D)Average daily shares traded | 1.6M | 1.5M | 126K | 213K |
Evenly matched — TOI and TRAK each lead in 1 of 2 comparable metrics.
Analyst Outlook
Evenly matched — AIOT and TRAK each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: TOI as "Buy", AIOT as "Buy", TRAK as "Buy", GEOS as "Hold". Consensus price targets imply 155.0% upside for TRAK (target: $24) vs 50.7% for TOI (target: $8). For income investors, AIOT offers the higher dividend yield at 17.85% vs TRAK's 0.92%.
| Metric | TOIThe Oncology Inst… | AIOTPowerFleet, Inc. | TRAKReposiTrak, Inc. | GEOSGeospace Technolo… |
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Hold |
| Price TargetConsensus 12-month target | $8.00 | $8.00 | $24.00 | — |
| # AnalystsCovering analysts | 5 | 5 | 1 | 8 |
| Dividend YieldAnnual dividend ÷ price | — | +17.8% | +0.9% | — |
| Dividend StreakConsecutive years of raises | — | 1 | 4 | — |
| Dividend / ShareAnnual DPS | — | $0.75 | $0.09 | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +0.5% | +1.9% | +0.7% |
Evenly matched — AIOT and TRAK each lead in 1 of 2 comparable metrics.
Key Takeaway
TRAK leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). GEOS leads in 1 (Valuation Metrics). 2 tied.
Best OverallReposiTrak, Inc. (TRAK)Leads 2 of 6 categories
Loading custom metrics...
TOI vs AIOT vs TRAK vs GEOS: Key Questions Answered
9 questions · data-driven answers · updated daily
01Is TOI or AIOT or TRAK or GEOS a better buy right now?
For growth investors, The Oncology Institute, Inc.
(TOI) is the stronger pick with 27. 8% revenue growth year-over-year, versus -18. 3% for Geospace Technologies Corporation (GEOS). ReposiTrak, Inc. (TRAK) offers the better valuation at 26. 9x trailing P/E (25. 4x forward), making it the more compelling value choice. Analysts rate The Oncology Institute, Inc. (TOI) a "Buy" — based on 5 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — TOI or AIOT or TRAK or GEOS?
Over the past 5 years, ReposiTrak, Inc.
(TRAK) delivered a total return of +63. 0%, compared to -47. 4% for The Oncology Institute, Inc. (TOI). Over 10 years, the gap is even starker: TRAK returned +4. 7% versus GEOS's -60. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — TOI or AIOT or TRAK or GEOS?
By beta (market sensitivity over 5 years), ReposiTrak, Inc.
(TRAK) is the lower-risk stock at 0. 97β versus PowerFleet, Inc. 's 2. 71β — meaning AIOT is approximately 179% more volatile than TRAK relative to the S&P 500. On balance sheet safety, Geospace Technologies Corporation (GEOS) carries a lower debt/equity ratio of 1% versus 64% for PowerFleet, Inc. — giving it more financial flexibility in a downturn.
04Which is growing faster — TOI or AIOT or TRAK or GEOS?
By revenue growth (latest reported year), The Oncology Institute, Inc.
(TOI) is pulling ahead at 27. 8% versus -18. 3% for Geospace Technologies Corporation (GEOS). On earnings-per-share growth, the picture is similar: PowerFleet, Inc. grew EPS 60. 6% year-over-year, compared to -52. 0% for Geospace Technologies Corporation. Over a 3-year CAGR, AIOT leads at 42. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — TOI or AIOT or TRAK or GEOS?
ReposiTrak, Inc.
(TRAK) is the more profitable company, earning 30. 9% net margin versus -14. 1% for PowerFleet, Inc. — meaning it keeps 30. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: TRAK leads at 27. 5% versus -10. 2% for GEOS. At the gross margin level — before operating expenses — TRAK leads at 83. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Is TOI or AIOT or TRAK or GEOS more undervalued right now?
Analyst consensus price targets imply the most upside for TRAK: 155.
0% to $24. 00.
07Which pays a better dividend — TOI or AIOT or TRAK or GEOS?
In this comparison, AIOT (17.
8% yield), TRAK (0. 9% yield) pay a dividend. TOI, GEOS do not pay a meaningful dividend and should not be held primarily for income.
08Is TOI or AIOT or TRAK or GEOS better for a retirement portfolio?
For long-horizon retirement investors, ReposiTrak, Inc.
(TRAK) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 97), 0. 9% yield). Geospace Technologies Corporation (GEOS) carries a higher beta of 2. 09 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (TRAK: +4. 7%, GEOS: -60. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between TOI and AIOT and TRAK and GEOS?
These companies operate in different sectors (TOI (Healthcare) and AIOT (Technology) and TRAK (Technology) and GEOS (Energy)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: TOI is a small-cap high-growth stock; AIOT is a small-cap income-oriented stock; TRAK is a small-cap quality compounder stock; GEOS is a small-cap quality compounder stock. AIOT, TRAK pay a dividend while TOI, GEOS do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.